Title
Management of Moderate to Severe Ulcerative Colitis
Authoring Organization
Publication Month/Year
January 13, 2020
Last Updated Month/Year
October 3, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
This document presents the official recommendations of the American Gastroenterological Association (AGA) on the management of moderate to severe ulcerative colitis (UC). This guideline addresses the medical management of adult outpatients with moderate to severe UC, as well as the medical management of adult hospitalized patients with ASUC. The guideline focuses on immunomodulators, biologics, and small molecules for induction and maintenance of remission (for moderate to severe UC) and decreasing the risk of colectomy (for ASUC).
Target Patient Population
Adult outpatients with moderate to severe ulcerative colitis (UC) and adult hospitalized patients with acute severe ulcerative colitis (ASUC)
Inclusion Criteria
Male, Female, Adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment, Management
Keywords
inflammatory bowel disease, ulcerative colitis, ulcer
Source Citation
Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S, on behalf of the American Gastroenterological Association Institute Clinical Guidelines Committee, AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis, Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.01.006.